Browse Alphabetically by Name |
|
|
|
C14216 Tandutinib(CT 53518) (387867-13-2) |
|
Catalog No.: |
C14216 |
CAS No.: |
387867-13-2 |
Synonym: |
MLN518,CT53518 |
Chemical Name: |
4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide; (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide |
Molecular Formula: |
C31H42N6O4 |
Molecular Weight: |
562.70 |
|
|
Appearance: |
Yellowish powder |
Solubility: |
Soluble in DMSO and chloroform |
Purity: |
>99% |
Storage: |
at -20° C |
Original QC Data: |
|
Shipping Conditions: |
Ambient Temp. |
|
|
Price and Availability of Tandutinib(CT 53518): |
Size |
Price |
Stock |
10mg |
USD |
In stock |
50mg |
USD |
In stock |
100mg |
USD |
In stock | |
Contact us for competitive discounts on bulk quantities |
|
|
An oral tyrosine kinase inhibitor (TKI), targeting FLT3 (FMS-Like Tyrosine kinase-3), c-KIT and PDGFR, thereby inhibiting cellular proliferation and inducing apoptosis. |
1. Brownlow, N., et al. 2008. Leukemia. 22: 1452-1453. PMID: 18185521 2. DeAngelo, D.J., et al. 2006. Blood. 108: 3674-3681. PMID: 16902153 |
View Related Products by Target: |
|